Laboratory studies on pathophysiology of the catastrophic antiphospholipid syndrome

Autoimmunity Reviews

Volumn 6, Issue 2, 2006, Pages 68-71

  Espinosa, Gerard ^a   Bucciarelli, Silvia ^a   Cervera, Ricard ^a   Gómez Puerta, José A ^a   Font, Josep ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Catastrophic APS; Multiorgan dysfunction syndrome; Pathogenesis; Systemic inflammatory distress syndrome; Thrombotic microangioapathy

Indexed keywords

CLOPIDOGREL; CYCLOSPORIN A; CYTOKINE; TICLOPIDINE;

ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG RELEASE; HUMAN; INFLAMMATION; LABORATORY TEST; MICROANGIOPATHY; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY; REVIEW; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TERMINAL DISEASE; THROMBOSIS; TISSUE NECROSIS;

ANTIPHOSPHOLIPID SYNDROME; CATASTROPHIC ILLNESS; DIAGNOSIS, DIFFERENTIAL; HUMANS; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 33751324826     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2006.06.006     Document Type: Review

References (21)

1. Asherson R.A. The catastrophic antiphospholipid syndrome. J Rheumatol 19 (1992) 508-512
2. Asherson R.A., Cervera R., Piette J.C., et al. Catastrophic antiphospholipid syndrome: clinical and laboratory features of 50 patients. Medicine (Baltimore) 77 (1998) 195-207
3. Asherson R.A., Cervera R., Piette J.C., et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 80 (2001) 355-376
4. Asherson R.A., Cervera R., de Groot P.R., et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 12 (2003) 530-534
5. Piette J.C., Cervera R., Levy R.A., et al. The catastrophic antiphospholipid syndrome-Asherson's syndrome. Ann Med Interne (Paris) 154 (2003) 195-196
6. Asherson R.A. The catastrophic antiphospholipid (Asherson's) syndrome in 2004. Autoimmu Rev 4 (2005) 48-54
7. Cervera R., Piette J.C., Font J., et al. Antiphospholipid syndrome: clinical and immnologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 46 (2002) 1019-1027
8. Meroni P.L., Raschi E., Camera M., et al. Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome. J Autoimmun 15 (2000) 237-240
9. Bhatia M., and Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 202 (2004) 145-156
10. Bolton C.F. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 24 (1996) 1408-1416
11. Ren J., and Wu S. A burning issue: do sepsis and systemic inflammatory response syndrome (SIRS) directly contribute to cardiac dysfunction?. Front Biosci 11 (2006) 15-22
12. Kitchens C.S. Thrombotic storm: when thrombosis begets thrombosis. Am J Med 104 (1998) 381-385
13. Asherson R.A. Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome. Immunobiology 210 (2005) 727-733
14. Asherson R.A., and Shoenfeld Y. The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome. Molecular mimicry?. J Rheumatol 27 (2000) 12-14
15. Cohen J. The immunopathogenesis of sepsis. Nature 420 (2002) 885-891
16. 2 glycoprotein I) antibodies. Arthritis Rheum 44 (2001) 2870-2878
17. Raschi E., Testoni C., Bossio D., et al. Role of MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood 101 (2003) 3495-3500
18. Blank M., Asherson R.A., Cervera R., et al. Antiphospholipid syndrome infectious origin. J Clin Immunol 24 (2004) 12-23
19. Lämmle B., Kremer Hovinga J.A., and Alberio L. Thrombotic thrombocytopenic purpura. J Thromb Haemost 3 (2005) 1663-1675
20. Amoura Z., Costedoat-Chalumeau N., Veyradier A., et al. Thrombotic thrombocytopenic purpura with severe ADAMTS-13 deficiency in two patients with primary antiphospholipid syndrome. Arthritis Rheum 50 (2004) 3260-3264
21. Rieger M., Manucci P.M., Kremer Hovinga J.A., et al. ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases. Blood 106 (2005) 1262-1267